JCR Pharmaceuticals Co., Ltd.
JCRRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $77 | $66 | $84 | $89 |
| - Cash | $0 | $13 | $13 | $16 |
| + Debt | $0 | $40 | $38 | $32 |
| Enterprise Value | $77 | $93 | $109 | $105 |
| Revenue | $0 | $0 | $7 | $9 |
| % Growth | 45.4% | -99.2% | -22% | – |
| Gross Profit | $0 | $0 | $3 | $7 |
| % Margin | 84.3% | 72.1% | 39.8% | 71% |
| EBITDA | $0 | $0 | -$5 | $1 |
| % Margin | 32% | 335.5% | -70.9% | 8% |
| Net Income | $0 | -$1 | -$4 | $0 |
| % Margin | 17.6% | -918.3% | -58.2% | 1.2% |
| EPS Diluted | 0.13 | -4.48 | -34.28 | 0.93 |
| % Growth | 102.9% | 86.9% | -3,786% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |